deltatrials
Unknown NA INTERVENTIONAL 1-arm NCT02657707

Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis

Pivotal Study of the MicroVention, Inc. Carotid Artery Stent System Used in Conjunction With the Nanoparasol® Embolic Protection System for the Treatment of Carotid Artery Stenosis in Patients at Elevated Risk for Adverse Events From Carotid Endarterectomy.(CONFIDENCE Trial)

Sponsor: Microvention-Terumo, Inc.

Updated 17 times since 2017 Last updated: Feb 27, 2023 Started: Apr 21, 2016 Primary completion: Apr 8, 2022 Completion: May 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Carotid Artery Stenosis, this trial is ongoing. The trial is conducted by Microvention-Terumo, Inc. and has accumulated 17 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Study Description(click to expand)

Up to 295 patients will be enrolled for this study. All potential patients being considered for the study should have been diagnosed with significant carotid artery stenosis and be considered a high perioperative risk for carotid endarterectomy. Patients will be evaluated through screening, pre-procedure, index procedure, post-procedure. Follow-up visits will be completed at 30 days, 6 months, and 12, 24, and 36 months post-procedure.

Up to 295 patients will be enrolled for this study. All potential patients being considered for the study should have been diagnosed with significant carotid artery stenosis and be considered a high perioperative risk for carotid endarterectomy.

Patients will be evaluated through screening, pre-procedure, index procedure, post-procedure. Follow-up visits will be completed at 30 days, 6 months, and 12, 24, and 36 months post-procedure.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshot~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Oct 2020 · 24 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~May 2021 · 3 months · monthly snapshot~May 2021 – ~Mar 2022 · 10 months · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~Mar 2023 · 11 months · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshot~Sep 2025 – present · 7 months · monthly snapshot

Change History

17 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Mar 2025 — Sep 2025 [monthly]

    Unknown NA

    Status: Active Not RecruitingUnknown

  3. Sep 2024 — Mar 2025 [monthly]

    Active Not Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  5. Mar 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

Show 12 earlier versions
  1. Apr 2022 — Mar 2023 [monthly]

    Active Not Recruiting NA

  2. Mar 2022 — Apr 2022 [monthly]

    Active Not Recruiting NA

  3. May 2021 — Mar 2022 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  4. Feb 2021 — May 2021 [monthly]

    Recruiting NA

  5. Jan 2021 — Feb 2021 [monthly]

    Recruiting NA

  6. Oct 2020 — Jan 2021 [monthly]

    Recruiting NA

  7. Oct 2018 — Oct 2020 [monthly]

    Recruiting NA

  8. Jun 2018 — Oct 2018 [monthly]

    Recruiting NA

  9. Mar 2018 — Jun 2018 [monthly]

    Recruiting NA

  10. Feb 2018 — Mar 2018 [monthly]

    Recruiting NA

  11. Feb 2017 — Feb 2018 [monthly]

    Recruiting NA

  12. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Microvention-Terumo, Inc.
Data source: Microvention-Terumo, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .